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Abstract
Gram-negative bacteria constitutively release outer membrane vesicles (OMVs) during cell 
growth that play significant roles in bacterial survival, virulence and pathogenesis. In this study, 
comprehensive proteomic analysis of OMVs from a human gastrointestinal pathogen 
Campylobacter jejuni NCTC11168 was performed using high-resolution mass spectrometry. The 
OMVs of C. jejuni NCTC11168 were isolated from culture supernatants then characterized using 
electron microscopy and dynamic light scattering revealing spherical OMVs of an average 
diameter of 50 nm. We then identified 134 vesicular proteins using high-resolution LTQ-Orbitrap 
mass spectrometry. Subsequent functional analysis of the genes revealed the relationships of the 
vesicular proteins. Furthermore, known N-glycoproteins were identified from the list of the 
vesicular proteome, implying the potential role of the OMVs as a delivery means for biologically 
relevant bacterial glycoproteins. These results enabled us to elucidate the overall proteome profile 
of pathogenic bacterium C. jejuni and to speculate on the function of OMVs in bacterial infections 
and communication.
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Introduction
Gram-negative bacteria secrete outer membrane vesicles (OMVs) that consist of 
lipopolysaccharides (LPS), outer membrane proteins, periplasmic proteins, outer membrane 
lipids, and virulence factors [1, 2]. In pathogens, OMVs are released extracellularly often 
attaching to host cells through adhesive molecules then transferring compounds that may 
modulate the host immune response [3]. They have been used for vaccine development [4] 
*Correspondence: William M. Clemons, Jr., Division of Chemistry and Chemical Engineering, California Institute of Technology, 
1200 East California Boulevard, Pasadena, CA 91125, USA, Phone: +1-626-395-1796; FAX: +1-626-395-8826, 
clemons@caltech.edu. 
HHS Public Access
Author manuscript
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Published in final edited form as:
J Proteomics. 2014 February 26; 98: 90–98. doi:10.1016/j.jprot.2013.12.014.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
or for delivery of foreign proteins such as beta-lactamase [5]. Antigenic OMVs from 
Neisseria meningitidis were used to develop an administrative medicine to combat the 
microbial infection by boosting host immune response [6, 7]. Thus, bacterial OMVs have 
drawn much attention due both to their biological functions and potential use.
The human food-borne pathogen Campylobacter jejuni is the major bacterial causative agent 
of food poisoning [8] and infections can lead to Guillain-Barré syndrome (GBS), a disorder 
affecting the peripheral nervous system [9]. Currently, diverse approaches using genomics 
and proteomics techniques are being applied to better understand the pathogenesis and 
physiology of this medically important organism [10–13]. In particular, various proteins (i.e. 
outer membrane proteins) in C. jejuni have been investigated for the immunogenic 
properties and potential for use in vaccine development [14–16].
Due to the lack of a clear understanding for the biological roles of OMVs, the last decade 
has seen proteomic analysis of OMVs from a variety of pathogenic bacterial species such as 
Escherichia coli, Helicobacter pylori, Legionella pneumophila, Neisseria meningitidis, 
Pseudomonas aeruginosa etc [17–23]. The vesicular proteome of C. jejuni, however, has yet 
to be sufficiently investigated, despite the likelihood of their role in pathogenesis and 
virulence. Currently, the OMVs of C. jejuni have only been examined as the delivery 
mechanism for certain toxins [24].
In this study, we investigated the proteome profile of OMVs from the clinically isolated C. 
jejuni NCTC11168 using high-resolution LTQ-Orbitrap mass spectrometry (FT MS). 
Purified OMVs from bacterial culture supernatants were characterized and prepared for MS 
analysis. The results of this analysis showed a diverse set of enzymes and known virulence 
factors were present in the OMVs and may play a meaningful role during host-cell 
interaction.
Material and methods
Purification of OMVs from bacterial culture supernatants
C. jejuni NCTC11168 (ATCC #700819), originally isolated from a patient, was grown in 
brain heart infusion (BHI) media under microaerobic conditions (1% O2, 10% CO2, 10% H2 
and balanced with N2) at 37°C. A 10 mL overnight culture was inoculated to 1L of media 
that was allowed to grow 18 h to mid-log phase. OMVs were purified from culture 
supernatants, as described previously with some modifications [17]. Briefly, the cells were 
pelleted using centrifugation at 6,000×g for 20 min at 4°C twice. The supernatants were 
filtered with 0.22 μm filter device to remove remaining cells. The resultant was centrifuged 
at 30,000×g for 40 min at 4°C to remove cell debris, large cell bulges or vesicle aggregates, 
and finally centrifuged with 150,000×g for 3 h at 4°C. The pellets were resuspended with 
1.6 mL of 10% OptiPrep iodixanol solution (Sigma-Aldrich)/PBS, then gently overlaid onto 
the top of 40% (1.9 mL) and 50% (3 mL) of OptiPrep/PBS solutions. The OMVs were 
isolated from the protein-rich fractions with ultracentrifugation at 150,000×g for 2 h at 4°C, 
then dissolved with PBS buffer and stored at −80°C prior to use.
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Transmission electron microscopy (TEM)
Isolated OMVs were ten-fold diluted with deionized water and 3 μL of this suspension was 
added to glow discharged, 200-mesh formvar-carbon coated grids (Pella Inc.), then the 
samples were stained with 1% uranyl acetate for negative staining. Samples were applied for 
45s, blotted with filter paper and air dried. Digital images were recorded at 67,000× 
magnification, on a Tecnai T12 electron microscope (FEI Company, Hillsboro, OR) 
operating at 120 keV acceleration and equipped with a Gatan Ultrascan 2×2K CCD camera.
Dynamic light scattering (DLS)
The size distribution of the OMVs was determined using a DynaPro NanoStar light 
scattering instrument (Wyatt Technology, Santa Barbara, CA). DLS data were collected 
from 100 μL of PBS-dissolved OMVs by ten 5 s acquisitions at 25°C with a laser at a 
wavelength of 659 nm.
Western Blot analysis
Subcellular fractions of C. jejuni were analyzed by western blotting with soybean agglutinin 
lectin (SBA, Vector Laboratories Inc, CA). Briefly, the fractionated samples were separated 
on 12% acrylamide gels, transferred to polyvinylidene fluoride (PVDF) membranes by 
Trans-Blot Turbo transfer system (Bio-Rad Laboratories, Inc., Hercules, CA), and probed 
with fluorescein-conjugated SBA lectins (50 nM in PBS) after blocking with 2.5% (w/v) 
bovine serum albumin in PBS for 1 h at room temperature. After washing unbound lectins, 
the membranes were scanned with Storm 860 Molecular Imager (Molecular Dynamics) at 
excitation and emission wavelengths of 450 nm and 520 nm for detection.
Sample preparation for MS analysis
Fifty micrograms of total proteins in OMV sample were digested with trypsin (Promega, 
Madison, WI) on Amicon ultra centrifugal filter units (30K molecular weight cutoff, 
Millipore, Billerica, MA) based on a method (FASP; filter-aided sample preparation) 
developed by Manza et al. [25] and modified by Wisniewski et al. [26]. The OMV and 
whole lysate (WL) were first dissolved in 1% (w/v) SDS and 0.1 M DTT in 100 mM Tris-
HCl (pH 7.6) and incubated at 95°C for 5 min, respectively. Alkylation and digestion were 
performed according to a published protocol [21]. Desalting of digested peptides was 
performed on Empore High-Performance extraction disk cartridges C18-SD (3M, St. Paul, 
MN) as described previously [26]. The final peptide samples were dried and reconstituted 
with 0.1% (v/v) formic acid/water for MS analysis.
NanoLC-MS/MS analysis
Mass spectrometric experiments were performed using a nanoLC LTQ-Orbitrap mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano-
electrospray ion source and an Easy II nanoLC, as described previously [27] with some 
modifications. A 5 μL sample (1 μg of total proteins) was loaded on a self-packed 5 μm 
Reprosil C18AQ (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) column (75 μm × 
150 mm). The mobile phases consisted of acetonitrile/formic acid/water (2/0.2/98, v/v/v) for 
A and acetonitrile/formic acid/water (80/20/0.2, v/v/v) for B. The FASP processed samples 
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were analyzed on a 150 min gradient from 2 to 30% B. The LTQ-Orbitrap was operated in 
data-dependent acquisition mode to automatically alternate between a full scan (m/z 300–
1700) in the Orbitrap and CID MS/MS scans in the linear ion trap. The ten most intense 
peptide ions were isolated for fragmentation. Helium was used as collision gas for CID. 
Normalized collision energy was 35% and activation time was 30 ms. Unless otherwise 
noted, three replicate measurements were made at each MS setting. Data acquisition was 
controlled by Xcalibur 2.0.7 and Tune 2.4 software (Thermo Fisher Scientific).
Database searching
Raw files were processed and searched using MaxQuant (version 1.2.2.5). Spectra were 
searched against the total predicted C. jejuni sequences from UNIPROT (1624 sequences, 
downloaded on 04/12/09) and common contaminants (262 sequences). The spectra were 
also searched against an equal number of decoy sequences to estimate the false discovery 
rate (FDR), similar to as described previously [28]. The specified enzyme was trypsin with 
up to two missed cleavages. Oxidation of methionine (+15.9949) and acetylation of protein 
N-terminus (+42.0106) were specified as variable modifications and carbamidomethylation 
of cysteine (+57.0215) was specified as a fixed modification. All other parameters were the 
default, including a fragment ion tolerance of 0.5 Da and a maximum precursor ion 
tolerance of 6 ppm after recalibration. Identifications were filtered to curate a dataset with 
less than 1% FDR at both the peptide and protein level.
Bioinformatic analyses
Prediction of a signal peptide for the general secretory (Sec) or the twin-arginine 
translocation (Tat) pathway of the vesicular proteins was performed by PRED-TAT software 
(http://www.compgen.org/tools/PRED-TAT) [29] and the predicted Tat motif was obtained 
from TATFIND 1.4 server (http://signalfind.org/tatfind.html) [30]. Additional prediction of 
the signal peptide for vesicular proteins was done using the SignalP 4.1 server (http://
www.cbs.dtu.dk/services/SignalP) [31] and using PrediSi software (http://www.predisi.de) 
[32]. A consensus motif for N-glycosylation (D/E-X1-N-X2-S/T; X1 and X2 can be any 
amino acids, except proline) was searched using an in-house algorithm.
Results
Isolation and characterization of OMVs from C. jejuni NCTC11168
OMVs, secreted by C. jejuni into the extracellular milieu, were prepared from culture 
supernatants by serial centrifugation to remove cells and larger vesicles. The isolated OMVs 
were fixed and examined by transmission electron microscopy (TEM). The electron 
micrographs revealed that the OMVs of C. jejuni are spherical in shape with a generally 
uniform size distribution (Fig. 1A). This method dehydrates the vesicles resulting in an 
average diameter of 50 nm. Some of the vesicles have collapsed revealing the bilayer (Fig. 
1A, white arrow).
Dynamic light scattering (DLS) was used to get an accurate measure of hydrated OMVs. 
This method directly measures particle size confirming, the homogeneous size distribution 
seen by TEM. Hydrated, the mean hydrodynamic radius was 77.5 ± 4.6 nm (Fig. 1B). 
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OMVs prepared in the laboratory may not reflect the natural population of OMVs but the 
nano-sized OMVs are considered to biologically most relevant due to their ability to access 
a variety of environments within the host.
Proteome profiling of OMVs using MS
Along with purifying the OMVs, the periplasm and outer membrane were fractionated. 
These three sample pools were separated by SDS-PAGE and visualized by Coomassie 
staining (Fig. 1C). Comparing the bands on the gel, OMVs appeared to possess both outer 
membrane and periplasmic proteins; however, there were distinct differences indicating that 
the OMVs were unique from both. Soybean agglutinin lectin (SBA)-reactive bands were 
also observed from the vesicular proteins in Western Blot analysis, supporting the likely 
existence of glycoproteins in the membrane vesicles (Fig. 1D). It should be pointed out that 
the intensity of the positive bands from the OMVs was relatively lower than those from 
other samples, indicating that only a small fraction of glycoproteins are present in OMV 
when compared to whole cell lysates. OMV proteins were digested by trypsin and the 
subsequent peptides were analyzed using nanoLC-MS/MS with a high resolution LTQ-
Orbitrap. Raw data were searched against a UNIPROT protein database of predicted C. 
jejuni proteins. The experiment was performed three times. A total of 283 vesicular proteins 
were observed in the purified OMV samples. 134 of these proteins were identified in two 
out three experiments with high confidence (Table S1) and these were functionally 
classified. The vesicular proteins were categorized by the predicted subcellular localizations 
and biological functions (Fig. 2A and B). We observed 48 membrane-associated proteins 
(36%), 15 periplasmic proteins (11%) and 43 cytosolic proteins (32%). Twenty eight (21%) 
of them remain unknown, but five of these were predicted to possess signal peptides, 
indicating that they are more likely periplasmic proteins. In addition, the functional groups 
‘energy production and conversion’, ‘cell wall/membrane/envelope biogenesis’, and ‘cell 
motility’ were present. We also observed 64 enzymes including 20 oxidoreductases (15%), 
18 transferases (13%), 5 hydrolases (4%), 7 lyases (5%), 6 isomerases (5%) and 8 ligases 
(6%), (Fig. 2C).
Functional annotation of the genes of the vesicular proteins
To interpret the functional relationship of the diverse set of genes identified from the OMVs, 
the vesicular proteins were functionally annotated by DAVID tools [33]. The 134 high-
quality identifications from the OMV samples were compared to 774 genes that were 
identified from whole-cell lysate of C. jejuni in this study (data not shown). The lists of 
functional annotation terms of related genes and clusters of the annotated terms enriched in 
the OMV samples can be found in Table S2 and S3. Among the terms, OMV proteins were 
found to be enriched for terms related to ‘energy production’ and ‘respiratory metabolism’, 
indicating a potential role of OMVs in respiration. Flagellar assemble- and cell adhesion-
related genes were also enriched in the OMV samples. Interestingly, some of the known N-
linked glycoproteins, which are encoded by cjaA, dsbI, kpsD, napA, Cj0089, Cj0114, 
Cj0152c, Cj0268c, Cj0404, Cj0511 and Cj0694, were found in the vesicles. The annotation 
terms, which were not clustered in this enrichment analysis, are listed in Table S4.
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Signal peptide and N-glycosylation motifs in vesicular proteins
Signal peptide predictors were used to further characterize the identified vesicular proteins 
of C. jejuni since most outer membrane and periplasmic proteins are known to have a signal 
peptide sequence in their N-termini that marks them for localization to the periplasm [34]. 
Prediction of signal peptides in the vesicular proteins was performed using diverse 
bioinformatics tools such as SignalP 4.1, PrediSi, PRED-TAT and TATFIND 1.4, then the 
signal motif for the twin-arginine translocation (Tat) pathway was discriminated from the 
signal peptide for the general secretory (Sec) pathway [35]. Finally, fifty three vesicular 
proteins (40% of the total) were predicted to carry a signal peptide or a TM domain. Among 
those, eight vesicular proteins (6% of the total) were predicted to use the Tat apparatus, 
while 35 proteins (26% of the total) were assumed to be localized via the Sec pathway (Fig. 
3A). The substrates for the Tat pathway were classified in proteins that play a role in 
electron transports and/or anaerobic respiration. Predicted Tat substrates and their sequences 
are listed in Table 2.
In addition, the bacterial N-glycosylation motif (i.e. D/E-X1-N-X2-S/T) was searched from 
the list of vesicular proteins. Thirty five proteins had the motif in their sequences, but only 
11 of them have been experimentally confirmed [36, 37]. Regardless of the presence or 
absence of signal peptides, the glycosylation motif was present in 35 proteins and certain 
proteins seem to be actually glycosylated (Fig. 3B and C).
Discussions
The analysis of the OMVs isolated from C. jejuni unveiled the vesicular protein pool 
providing insight toward the role of OMVs in bacterial physiology and pathology. We 
isolated a homogeneous population of spherical OMVs, identifying 134 vesicular proteins 
by mass spectrometry. These were categorized by their biological function and predicted 
cellular location. The most enriched terms were related to energy generations (i.e. aerobic 
respiration and TCA cycle) while the most abundant enzymes belonged to the 
oxidoreductase family. Flagellum assembly proteins were also highly represented.
Several of the observed enzymes, such as oxidoreductases, are known to be involved in the 
TCA cycle, generating energy by oxidation of certain substrates during respiration. Some 
respiratory enzymes such as nitrate reductase (NapA), nitrite reductase (NrfA) and cbb3-
type oxidase (CcoN) in C. jejuni are known to play a significant role in host colonization 
[38]. The napA or nrfA deficient strain showed a dramatically reduced level of colonization, 
while the ccoN mutant completely lost the ability to colonize in chicks [38]. It is also known 
that, instead of oxygen, C. jejuni can use nitrate, formate, DMSO and/or trimethylamine N-
oxide (TMAO) as a respiratory electron acceptor under anaerobic condition, which implies 
that the ability of the reductases to use a variety of alternative acceptors is crucial in the 
pathology and physiology [38, 39]. Recently, Liu and coworkers reported that the change of 
its respiration mode of C. jejuni by the expression levels of those respiratory chain-
associated enzymes is closely associated with the bacterial survival in host environments 
[11].
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In the analysis of signal peptides, eight vesicular proteins were predicted to be localized via 
the twin-arginine translocation (Tat) pathway and were classified in cofactor-containing 
proteins involved in electron transport chains. This agreed well with the previous results that 
the Tat machinery in bacteria is mainly responsible for the transport of cofactor-binding 
folded proteins across the cytoplasmic membrane [40]. Although only eight vesicular 
proteins were predicted to possess the Tat signal peptide, the actual Tat substrates being 
found in OMVs might be more substantial as Tat substrates can be secreted as part of a 
complex [40]. We also observed that some proteins have Sec signal peptides that contribute 
to a diverse range of cellular processes such as flagellin assembly, signal transduction, 
amino acid metabolism and virulence. In contrast to the Sec-protein translocation, the Tat-
derived protein transport seems to be more specifically used in adaptation and survival of C. 
jejuni in diverse environments. Thus, it is possible that OMVs can be used as an export route 
for these crucial enzymes into the environment, to assist in respiration; alternatively, it could 
be a route to secrete non-functioning enzymes.
This study also identified some cytoplasmic proteins in OMVs. While Horstman and Kuehn 
believe that cytoplasmic proteins should not be present in OMVs [41], many proteomics 
studies on OMVs confirmed their presence [18, 20, 42–45]. Further analyses are certainly 
necessary to confirm the presence or absence of cytoplasmic proteins in OMVs. It is 
nevertheless worth pointing out DNA and RNA is also present in OMV, indicating that 
some transcriptional and ribosomal proteins may be needed in OMVs [46–49].
Cell adherence is the first step in host-pathogen interactions and adhesion factors are 
important components of a bacterial infection [50]. In OMVs we find flagellar proteins, 
well-known adhesins [51, 52], such as flagellin A, B and flagellar hook proteins. Along with 
rhamnolipids, flagellar proteins of Pseudomonas aeruginosa are known to be a major 
inducing factor of psoriasis in human skin [53]. Therefore, the flagellin assembly proteins 
found in the OMVs of C. jejuni might have some role in bacterial host interaction.
Outer membrane proteins (OMPs), expected to be found in OMVs, were observed such as 
pore-forming proteins (PorA and Omp50), fibronectin-binding proteins (CadF and Cj1279c) 
and a surface antigen (CjaA), each known virulence factors [15, 54–60]. In addition, several 
putative lipoproteins (Cj0089, Cj0396c, Cj0406c and Cj0497) and putative membrane 
proteins (Cj0129c, Cj0152c, Cj0268c and Cj0404) were found that are additional virulence 
factor candidates.
C. jejuni protein N-glycosylation is associated with bacterial host interactions [61] and 11 
N-glycoproteins are found in the OMVs suggesting a role in pathogenesis. Among those, the 
surface-exposed CjaA is a well-known antigenic molecule and its glycosylation is known to 
be related to virulence [54, 62, 63]. An additional set of periplasmic and transmembrane N-
glycoproteins were also identified as OMV components.
Recently, Elmi and coworkers identified 151 vesicular proteins from a hypermotile strain C. 
jejuni 11168H and showed that the OMVs with functional virulence factors [i.e. cytolethal 
distending toxin (CDT)] can trigger host-immune responses [64]. We found 64 proteins in 
common from their protein list, but 70 proteins were unique (Fig. 4). This may represent the 
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dynamic nature of protein expression in C. jejuni regarding strain-dependency or growth 
conditions [57, 65]. OMVs prepared in the laboratory may not reflect the full proteome of 
OMVs from C. jejuni found in eukaryotic hosts due to the dynamic protein expression 
profile in response to environmental stimuli. The combined proteomic data provides 
valuable information toward understanding the pathogenesis and survival of C. jejuni.
We identified some lower confidence vesicular proteins of interest (Table S5), e.g. known 
toxins (CdtA and CdtB) and antigenic peptides (PEB1, PEB2 and PEB3) as well as 
multidrug efflux components (CmeA and CmeD). The virulence factor CDT complex 
consisting of CdtA, CdtB and CdtC is released via OMVs causing cell distending effects on 
host cells [24]. PEB1, a common antigen and cell-binding factor, can be used as a candidate 
vaccine [66]. CmeA and CmeD function as a multidrug efflux pump contributing to 
bacterial resistance to a broad range of antimicrobial agents [67, 68]. Some of these (i.e. 
CmeA and PEB3) are known to be N-glycosylated as well. As we observed in this study, the 
OMVs of C. jejuni possess a diverse set of proteins such as enzymes, adhesins, toxins etc., 
implying their latent functions in biological processes. Some of the vesicular proteins could 
be novel antibacterial targets, diagnostic markers of C. jejuni-mediated diseases and/or 
vaccine candidates. Therefore, further biological assays need to be performed to elucidate 
the biological roles of each protein in this context.
Recently, it was reported that the gram-positive pathogen Stapylococcus aureus produces 
membrane-derived vesicles (MVs) inducing apoptosis of host cells [69, 70] and a secreted 
vesicle was also observed from the solid spores of Streptomyces coelicolor, a kind of 
actinobacteria [71]. Taken together, most bacterial cells likely produce MVs; therefore, the 
secretion of bacterial MVs is likely a ubiquitously observed phenomenon. As the global 
vesicular proteome of human pathogens becomes clear we will better understand the various 
biological functions of OMVs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Sarkis Mazmanian for providing support for bacterial culture growth, Alasdair McDowall in the Cryo-
electron Microscopy Facility at the Broad Center for help with electron microscopy, and Axel Müller for 
optimizing the bacterial growth conditions (all at Caltech). We also thank V. Somalinga and A. Müller for critical 
reading of our paper. This work was supported by a Searle Scholar Fellowship and a Burroughs-Wellcome Fund 
Career Award to WMC. The PEL is supported by the Gordon and Betty Moore Foundation through Grant 
GBMF775 and the Beckman Institute.
References
1. Lee EY, Choi DS, Kim KP, Gho YS. Proteomics in gram-negative bacterial outer membrane 
vesicles. Mass Spectrom Rev. 2008; 27:535–55. [PubMed: 18421767] 
2. Mashburn-Warren L, McLean RJ, Whiteley M. Gram-negative outer membrane vesicles: beyond the 
cell surface. Geobiology. 2008; 6:214–9. [PubMed: 18459967] 
3. Kuehn MJ, Kesty NC. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes 
Dev. 2005; 19:2645–55. [PubMed: 16291643] 
Jang et al. Page 8
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
4. Collins BS. Gram-negative outer membrane vesicles in vaccine development. Discov Med. 2011; 
12:7–15. [PubMed: 21794204] 
5. Kim JY, Doody AM, Chen DJ, Cremona GH, Shuler ML, Putnam D, et al. Engineered bacterial 
outer membrane vesicles with enhanced functionality. J Mol Biol. 2008; 380:51–66. [PubMed: 
18511069] 
6. Findlow J, Balmer P, Yero D, Niebla O, Pajon R, Borrow R. Neisseria vaccines 2007. Expert Rev 
Vaccines. 2007; 6:485–9. [PubMed: 17669003] 
7. Findlow H, Southern J, Mabey L, Balmer P, Heyderman RS, Auckland C, et al. Immunoglobulin G 
subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate 
vaccine. Clin Vaccine Immunol. 2006; 13:507–10. [PubMed: 16603620] 
8. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. 
2001; 32:1201–6. [PubMed: 11283810] 
9. Fujimoto S, Amako K. Guillain-Barre syndrome and Campylobacter jejuni infection. Lancet. 1990; 
335:1350. [PubMed: 1971411] 
10. Pearson BM, Pin C, Wright J, I’Anson K, Humphrey T, Wells JM. Comparative genome analysis 
of Campylobacter jejuni using whole genome DNA microarrays. FEBS Lett. 2003; 554:224–30. 
[PubMed: 14596944] 
11. Liu X, Gao B, Novik V, Galan JE. Quantitative Proteomics of Intracellular Campylobacter jejuni 
Reveals Metabolic Reprogramming. PLoS Pathog. 2012; 8:e1002562. [PubMed: 22412372] 
12. Taboada EN, Acedillo RR, Carrillo CD, Findlay WA, Medeiros DT, Mykytczuk OL, et al. Large-
scale comparative genomics meta-analysis of Campylobacter jejuni isolates reveals low level of 
genome plasticity. J Clin Microbiol. 2004; 42:4566–76. [PubMed: 15472310] 
13. Cordwell SJ, Len AC, Touma RG, Scott NE, Falconer L, Jones D, et al. Identification of 
membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics 
technologies. Proteomics. 2008; 8:122–39. [PubMed: 18095373] 
14. Rathbun KM, Thompson SA. Mutation of PEB4 alters the outer membrane protein profile of 
Campylobacter jejuni. FEMS Microbiol Lett. 2009; 300:188–94. [PubMed: 19824902] 
15. Moser I, Schroeder W, Salnikow J. Campylobacter jejuni major outer membrane protein and a 59-
kDa protein are involved in binding to fibronectin and INT 407 cell membranes. FEMS Microbiol 
Lett. 1997; 157:233–8. [PubMed: 9435102] 
16. Blaser MJ, Hopkins JA, Vasil ML. Campylobacter jejuni outer membrane proteins are antigenic 
for humans. Infect Immun. 1984; 43:986–93. [PubMed: 6365789] 
17. Choi DS, Kim DK, Choi SJ, Lee J, Choi JP, Rho S, et al. Proteomic analysis of outer membrane 
vesicles derived from Pseudomonas aeruginosa. Proteomics. 2011; 11:3424–9. [PubMed: 
21751344] 
18. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, et al. Outer membrane vesicles 
from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological 
comparison with detergent-derived outer membrane vesicles. Proteomics. 2006; 6:1856–66. 
[PubMed: 16456881] 
19. Galka F, Wai SN, Kusch H, Engelmann S, Hecker M, Schmeck B, et al. Proteomic characterization 
of the whole secretome of Legionella pneumophila and functional analysis of outer membrane 
vesicles. Infect Immun. 2008; 76:1825–36. [PubMed: 18250176] 
20. Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, et al. Global proteomic profiling of 
native outer membrane vesicles derived from Escherichia coli. Proteomics. 2007; 7:3143–53. 
[PubMed: 17787032] 
21. Mullaney E, Brown PA, Smith SM, Botting CH, Yamaoka YY, Terres AM, et al. Proteomic and 
functional characterization of the outer membrane vesicles from the gastric pathogen Helicobacter 
pylori. Proteomics Clin Appl. 2009; 3:785–96. [PubMed: 21136987] 
22. Nally JE, Whitelegge JP, Aguilera R, Pereira MM, Blanco DR, Lovett MA. Purification and 
proteomic analysis of outer membrane vesicles from a clinical isolate of Leptospira interrogans 
serovar Copenhageni. Proteomics. 2005; 5:144–52. [PubMed: 15672460] 
23. Pierson T, Matrakas D, Taylor YU, Manyam G, Morozov VN, Zhou W, et al. Proteomic 
characterization and functional analysis of outer membrane vesicles of Francisella novicida 
Jang et al. Page 9
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
suggests possible role in virulence and use as a vaccine. J Proteome Res. 2011; 10:954–67. 
[PubMed: 21138299] 
24. Lindmark B, Rompikuntal PK, Vaitkevicius K, Song T, Mizunoe Y, Uhlin BE, et al. Outer 
membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter 
jejuni. BMC Microbiol. 2009; 9:220. [PubMed: 19835618] 
25. Manza LL, Stamer SL, Ham AJL, Codreanu SG, Liebler DC. Sample preparation and digestion for 
proteomic analyses using spin filters. Proteomics. 2005; 5:1742–5. [PubMed: 15761957] 
26. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for 
proteome analysis. Nat Methods. 2009; 6:359–62. [PubMed: 19377485] 
27. Kalli A, Hess S. Effect of mass spectrometric parameters on peptide and protein identification rates 
for shotgun proteomic experiments on an LTQ-orbitrap mass analyzer. Proteomics. 2012; 12:21–
31. [PubMed: 22065615] 
28. Sun N, Pan C, Nickell S, Mann M, Baumeister W, Nagy I. Quantitative proteome and 
transcriptome analysis of the archaeon Thermoplasma acidophilum cultured under aerobic and 
anaerobic conditions. J Proteome Res. 2010; 9:4839–50. [PubMed: 20669988] 
29. Bagos PG, Nikolaou EP, Liakopoulos TD, Tsirigos KD. Combined prediction of Tat and Sec 
signal peptides with hidden Markov models. Bioinformatics. 2010; 26:2811–7. [PubMed: 
20847219] 
30. Rose RW, Bruser T, Kissinger JC, Pohlschroder M. Adaptation of protein secretion to extremely 
high-salt conditions by extensive use of the twin-arginine translocation pathway. Mol Microbiol. 
2002; 45:943–50. [PubMed: 12180915] 
31. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from 
transmembrane regions. Nat Methods. 2011; 8:785–6. [PubMed: 21959131] 
32. Hiller K, Grote A, Scheer M, Munch R, Jahn D. PrediSi: prediction of signal peptides and their 
cleavage positions. Nucleic Acids Res. 2004; 32:W375–9. [PubMed: 15215414] 
33. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists 
using DAVID bioinformatics resources. Nat Protoc. 2009; 4:44–57. [PubMed: 19131956] 
34. Wickner W, Schekman R. Protein translocation across biological membranes. Science. 2005; 
310:1452–6. [PubMed: 16322447] 
35. De Buck E, Lammertyn E, Anne J. The importance of the twin-arginine translocation pathway for 
bacterial virulence. Trends Microbiol. 2008; 16:442–53. [PubMed: 18715784] 
36. Scott NE, Nothaft H, Edwards AV, Labbate M, Djordjevic SP, Larsen MR, et al. Modification of 
the Campylobacter jejuni N-linked glycan by EptC-mediated addition of phosphoethanolamine. J 
Biol Chem. 2012; 287:29384–96. [PubMed: 22761430] 
37. Scott NE, Parker BL, Connolly AM, Paulech J, Edwards AV, Crossett B, et al. Simultaneous 
glycan-peptide characterization using hydrophilic interaction chromatography and parallel 
fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation 
MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol Cell Proteomics. 2011; 
10:M000031-MCP201. [PubMed: 20360033] 
38. Weingarten RA, Grimes JL, Olson JW. Role of Campylobacter jejuni respiratory oxidases and 
reductases in host colonization. Appl Environ Microbiol. 2008; 74:1367–75. [PubMed: 18192421] 
39. Kurihara FN, Satoh T. A Single Enzyme Is Responsible for Both Dimethylsulfoxide and 
Trimethylamine-N-Oxide Respirations as the Terminal Reductase in a Photodenitrifier, 
Rhodobacter-Sphaeroides Fs Denitrificans. Plant and Cell Physiology. 1988; 29:377–9.
40. Lee PA, Tullman-Ercek D, Georgiou G. The bacterial twin-arginine translocation pathway. Annu 
Rev Microbiol. 2006; 60:373–95. [PubMed: 16756481] 
41. Horstman AL, Kuehn MJ. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin 
via outer membrane vesicles. J Biol Chem. 2000; 275:12489–96. [PubMed: 10777535] 
42. Molloy MP, Herbert BR, Slade MB, Rabilloud T, Nouwens AS, Williams KL, et al. Proteomic 
analysis of the Escherichia coli outer membrane. Eur J Biochem. 2000; 267:2871–81. [PubMed: 
10806384] 
43. Henry T, Pommier S, Journet L, Bernadac A, Gorvel JP, Lloubes R. Improved methods for 
producing outer membrane vesicles in Gram-negative bacteria. Res Microbiol. 2004; 155:437–46. 
[PubMed: 15249060] 
Jang et al. Page 10
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
44. Wei C, Yang J, Zhu J, Zhang X, Leng W, Wang J, et al. Comprehensive proteomic analysis of 
Shigella flexneri 2a membrane proteins. J Proteome Res. 2006; 5:1860–5. [PubMed: 16889407] 
45. Xu C, Lin X, Ren H, Zhang Y, Wang S, Peng X. Analysis of outer membrane proteome of 
Escherichia coli related to resistance to ampicillin and tetracycline. Proteomics. 2006; 6:462–73. 
[PubMed: 16372265] 
46. Dorward DW, Garon CF, Judd RC. Export and intercellular transfer of DNA via membrane blebs 
of Neisseria gonorrhoeae. J Bacteriol. 1989; 171:2499–505. [PubMed: 2496108] 
47. Kadurugamuwa JL, Beveridge TJ. Virulence factors are released from Pseudomonas aeruginosa in 
association with membrane vesicles during normal growth and exposure to gentamicin: a novel 
mechanism of enzyme secretion. J Bacteriol. 1995; 177:3998–4008. [PubMed: 7608073] 
48. Kolling GL, Matthews KR. Export of virulence genes and Shiga toxin by membrane vesicles of 
Escherichia coli O157:H7. Appl Environ Microbiol. 1999; 65:1843–8. [PubMed: 10223967] 
49. Yaron S, Kolling GL, Simon L, Matthews KR. Vesicle-mediated transfer of virulence genes from 
Escherichia coli O157:H7 to other enteric bacteria. Appl Environ Microbiol. 2000; 66:4414–20. 
[PubMed: 11010892] 
50. Pizarro-Cerda J, Cossart P. Bacterial adhesion and entry into host cells. Cell. 2006; 124:715–27. 
[PubMed: 16497583] 
51. McSweegan E, Walker RI. Identification and characterization of two Campylobacter jejuni 
adhesins for cellular and mucous substrates. Infect Immun. 1986; 53:141–8. [PubMed: 2873103] 
52. Grant CC, Konkel ME, Cieplak W Jr, Tompkins LS. Role of flagella in adherence, internalization, 
and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. 
Infect Immun. 1993; 61:1764–71. [PubMed: 8478066] 
53. Meyer-Hoffert U, Zimmermann A, Czapp M, Bartels J, Koblyakova Y, Glaser R, et al. Flagellin 
delivery by Pseudomonas aeruginosa rhamnolipids induces the antimicrobial protein psoriasin in 
human skin. PLoS One. 2011; 6:e16433. [PubMed: 21283546] 
54. Pawelec D, Rozynek E, Popowski J, Jagusztyn-Krynicka EK. Cloning and characterization of a 
Campylobacter jejuni 72Dz/92 gene encoding a 30 kDa immunopositive protein, component of the 
ABC transport system; expression of the gene in avirulent Salmonella typhimurium. FEMS 
Immunol Med Microbiol. 1997; 19:137–50. [PubMed: 9395059] 
55. Pei Z, Blaser MJ. PEB1, the major cell-binding factor of Campylobacter jejuni, is a homolog of the 
binding component in gram-negative nutrient transport systems. J Biol Chem. 1993; 268:18717–
25. [PubMed: 8360165] 
56. Zhang Q, Meitzler JC, Huang S, Morishita T. Sequence polymorphism, predicted secondary 
structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane 
protein. Infect Immun. 2000; 68:5679–89. [PubMed: 10992471] 
57. Scott NE, Cordwell SJ. Campylobacter proteomics: guidelines, challenges and future perspectives. 
Expert Rev Proteomics. 2009; 6:61–74. [PubMed: 19210127] 
58. Bolla JM, De E, Dorez A, Pages JM. Purification, characterization and sequence analysis of 
Omp50,a new porin isolated from Campylobacter jejuni. Biochem J. 2000; 352(Pt 3):637–43. 
[PubMed: 11104668] 
59. Bacon DJ, Johnson WM, Rodgers FG. Identification and characterisation of a cytotoxic porin-
lipopolysaccharide complex from Campylobacter jejuni. J Med Microbiol. 1999; 48:139–48. 
[PubMed: 9989641] 
60. Konkel ME, Garvis SG, Tipton SL, Anderson DE Jr, Cieplak W Jr. Identification and molecular 
cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni. Mol 
Microbiol. 1997; 24:953–63. [PubMed: 9220003] 
61. Szymanski CM, Burr DH, Guerry P. Campylobacter protein glycosylation affects host cell 
interactions. Infect Immun. 2002; 70:2242–4. [PubMed: 11895996] 
62. Wyszynska A, Zycka J, Godlewska R, Jagusztyn-Krynicka EK. The Campylobacter jejuni/coli 
cjaA (cj0982c) gene encodes an N-glycosylated lipoprotein localized in the inner membrane. Curr 
Microbiol. 2008; 57:181–8. [PubMed: 18584243] 
63. Muller A, Thomas GH, Horler R, Brannigan JA, Blagova E, Levdikov VM, et al. An ATP-binding 
cassette-type cysteine transporter in Campylobacter jejuni inferred from the structure of an 
extracytoplasmic solute receptor protein. Mol Microbiol. 2005; 57:143–55. [PubMed: 15948956] 
Jang et al. Page 11
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
64. Elmi A, Watson E, Sandu P, Gundogdu O, Mills DC, Inglis NF, et al. Campylobacter jejuni outer 
membrane vesicles play an important role in bacterial interactions with human intestinal epithelial 
cells. Infect Immun. 2012; 80:4089–98. [PubMed: 22966047] 
65. Zhang MJ, Xiao D, Zhao F, Gu YX, Meng FL, He LH, et al. Comparative proteomic analysis of 
Campylobacter jejuni cultured at 37C and 42C. Jpn J Infect Dis. 2009; 62:356–61. [PubMed: 
19762984] 
66. Du LF, Li ZJ, Tang XY, Huang JQ, Sun WB. Immunogenicity and immunoprotection of 
recombinant PEB1 in Campylobacter-jejuni-infected mice. World J Gastroenterol. 2008; 14:6244–
8. [PubMed: 18985818] 
67. Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring 
antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob 
Chemother. 2006; 57:52–60. [PubMed: 16303882] 
68. Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter 
jejuni. Antimicrob Agents Chemother. 2002; 46:2124–31. [PubMed: 12069964] 
69. Gurung M, Moon DC, Choi CW, Lee JH, Bae YC, Kim J, et al. Staphylococcus aureus produces 
membrane-derived vesicles that induce host cell death. PLoS One. 2011; 6:e27958. [PubMed: 
22114730] 
70. Lee EY, Choi DY, Kim DK, Kim JW, Park JO, Kim S, et al. Gram-positive bacteria produce 
membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived 
membrane vesicles. Proteomics. 2009; 9:5425–36. [PubMed: 19834908] 
71. Schrempf H, Koebsch I, Walter S, Engelhardt H, Meschke H. Extracellular Streptomyces vesicles: 
amphorae for survival and defence. Microb Biotechnol. 2011; 4:286–99. [PubMed: 21342473] 
72. Ingmer H, Brondsted L. Proteases in bacterial pathogenesis. Res Microbiol. 2009; 160:704–10. 
[PubMed: 19778606] 
Jang et al. Page 12
J Proteomics. Author manuscript; available in PMC 2015 August 12.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Characterization of OMVs of C. jejuni. (A) Negative-staining TEM of OMVs. The mean 
diameter of those OMVs is ca. 50 nm. This TEM image shows the bilayered and spherical 
shaped vesicle (white arrow). (B) Size distributions of OMVs measured by DLS. The 
averaged hydrodynamic radius of OMVs is ca. 75 nm. (C) SDS-PAGE profiles of OMVs. 
M, protein marker; WL, whole-cell lysate; PP, periplasmic proteins; OMP, outer membrane 
proteins. Filled arrows indicate proteins observed in both OMP and OMVs, while empty 
arrows show proteins observed in both PP and OMVs. (D) Western Blot result probed with 
fluorescein-conjugated SBA lectin. Filled arrows indicate the SBA-reactive bands in the 
OMV sample.
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Figure 2. 
Classification of cellular locations (A), functional annotation (B), and vesicular enzymes (C) 
of the identified proteins of OMVs. (B) The functional classification of the vesicular 
proteins was done based on the COG database (http://www.ncbi.nih.gov/COG).
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Figure 3. 
Pie charts and a bar graph of the relative percentages of the vesicular proteins regarding a 
signal peptide (SignalP) and/or an N-glycosylation motif (GlycoMotif). (A) A SignalP for 
Sec or Tat pathways as well as a TM domain was separated from the proteins not carrying 
any SignalP. (B) SignalP and/or GlycoMotif-containing proteins were discriminated. (C) 
Actual glycoproteins were separated from the proteins-containing only GlycoMotif or not at 
all.
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Figure 4. 
Venn-diagram showing the number of vesicular proteins identified from this study and the 
previous study done by Elmi et al. [64]. Sixty four proteins were identified in both studies, 
while 70 and 87 proteins were observed in each study. Dotted circle presents the vesicular 
proteins even including low-confidence ones, then numbers in parentheses present proteins 
including the low-confidence proteins.
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Table 2
List of predicted Tat signal substrates of the vesicular proteins by TATFIND 1.4.
Uniprot accession Description Gene Predicted Tat motifa
Q9PPD9 Periplasmic nitrate reductase napA
Q0PCC0 Molydopterin containing oxidoreductase Cj0005c
Q0PB73 Succinate dehydrogenase flavoprotein 
subunit sdhA
*
 Q0P8Y9 Ni/Fe-hydrogenase small chain hydA
Q0P8A3 Putative periplasmic oxidoreductase Cj1516
Q0P8A7 Putative formate dehydrogenase large 
subunit (Selenocysteine containing) fdhA
Q0P970 Ubiquinol-cytochrome c reductase iron-
sulfur subunit petA
Q0PBP1 Molybdopterin containing oxidoreductase Cj0264c
aSequence including predicted a Tat signal motif and a hydrophobic region. A Tat motif was bold and underlined. A hydrophobic region was italic 
and shaded.
*
This Tat substrate was not predicted using TATFIND 1.4, but using PRED-TAT. Therefore, the Tat motif sequence was predicted manually.
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